Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Beauty Health (SKIN) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for Beauty Health (SKIN) over the last 5 years, with Q3 2025 value amounting to 15.02%.

  • Beauty Health's EBITDA Margin rose 66900.0% to 15.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.25%, marking a year-over-year increase of 44600.0%. This contributed to the annual value of 9.88% for FY2024, which is 149000.0% up from last year.
  • Per Beauty Health's latest filing, its EBITDA Margin stood at 15.02% for Q3 2025, which was up 66900.0% from 29.85% recorded in Q2 2025.
  • In the past 5 years, Beauty Health's EBITDA Margin ranged from a high of 41.52% in Q1 2022 and a low of 317.96% during Q3 2021
  • For the 5-year period, Beauty Health's EBITDA Margin averaged around 35.92%, with its median value being 10.23% (2023).
  • Its EBITDA Margin has fluctuated over the past 5 years, first surged by 3160300bps in 2022, then tumbled by -749700bps in 2023.
  • Over the past 5 years, Beauty Health's EBITDA Margin (Quarter) stood at 26.51% in 2021, then soared by 134bps to 8.89% in 2022, then crashed by -185bps to 7.58% in 2023, then crashed by -114bps to 16.25% in 2024, then increased by 8bps to 15.02% in 2025.
  • Its EBITDA Margin was 15.02% in Q3 2025, compared to 29.85% in Q2 2025 and 12.89% in Q1 2025.